Physician profile
David J Sterna
NPI 1992870265
$1,416.25
in general payments reported to CMS, 2019-2025
12 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $280 · 2022: $105 · 2023: $134 · 2024: $125 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $357.32 | 2019-2024 | Misight Contact Lens, Myday Contact Lens |
| Ocular Therapeutix, INC. | $146.48 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $124.99 | 2019 | |
| Shire North American Group INC | $124.60 | 2019 | |
| Bausch & Lomb Americas INC. | $124.12 | 2025 | Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $121.23 | 2019-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $120.58 | 2020 | |
| Allergan, INC. | $104.93 | 2022 | |
| Optos, INC. | $68.19 | 2019 | |
| Lkc Technologies, INC. | $50.00 | 2025 | |
| Sight Sciences, INC. | $47.79 | 2019 | |
| Synergeyes, INC. | $26.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sterna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.